No evidence of Singulair link to mood changes
This article was originally published in Scrip
Executive Summary
Merck & Co's widely used asthma drug Singulair (montelukast) does not appear to be linked to mood changes, suicidality or suicide, American Lung Association researchers report in the Journal of Allergy and Clinical Immunology.